Book Now!

A Trusted Intravenous Iron Therapy for Iron Deficiency and Iron Deficiency Anemia

Iron deficiency is among the most common nutritional concerns in the world, yet it is frequently overlooked in routine medical care. The World Health Organization estimates that anemia affects roughly 30 percent of women between the ages of 15 and 49 globally—or 539 million individuals—with iron deficiency standing as the leading underlying cause.¹ 

For many patients, oral iron supplements are not enough. Intravenous iron therapy is designed to help restore iron stores quickly and more effectively. Venofer is an FDA-approved iron sucrose that is administered intravenously and has been used clinically for decades.² When oral iron is poorly tolerated, insufficiently absorbed, or unable to correct iron levels quickly enough, Venofer IV offers a reliable option for replenishing iron stores and supporting the body’s ability to produce healthy red blood cells.

What Is Venofer IV?

Venofer is the brand name for iron sucrose, a nanomedicine-class intravenous iron preparation that delivers elemental iron directly into the bloodstream.³ Once administered, the iron becomes available for uptake by the bone marrow, where it is incorporated into hemoglobin—the oxygen-carrying molecule inside red blood cells. Because Venofer bypasses the digestive tract entirely, it avoids the absorption limitations and gastrointestinal side effects that commonly accompany oral iron tablets.

Venofer is FDA-approved for the treatment of iron deficiency anemia in patients with chronic kidney disease, and it has a well-established safety and efficacy profile in a wide range of clinical settings, including gastrointestinal disorders, women’s health, cardiology, and oncology.² It is administered as a slow intravenous injection or infusion by a qualified clinician, typically in a series of treatment sessions designed to restore iron levels over a defined period.

Venofer IV Generic

What Is Iron Deficiency and Iron Deficiency Anemia?

Iron deficiency occurs when the body does not have enough iron to meet its physiological needs. When that deficiency progresses to the point of reducing the body’s ability to produce adequate hemoglobin, the condition is known as iron deficiency anemia.3 Iron deficiency and iron deficiency anemia can develop from a variety of causes, including: 

  • Inadequate dietary intake
  • Blood loss (such as from heavy menstrual cycles or gastrointestinal bleeding)
  • Increased iron demands during pregnancy
  • Gastrointestinal malabsorption
  • Chronic inflammatory conditions
  • Chronic kidney disease
  • Surgical histories that affect nutrient absorption.

Symptoms of Iron Deficiency and Iron Deficiency Anemia

The symptoms of iron deficiency can be subtle at first and often overlap with the general demands of a busy life, which is part of why the condition is so frequently overlooked. Common symptoms include:

  • Persistent fatigue and low energy
  • Shortness of breath on exertion
  • Dizziness or lightheadedness
  • Pale skin or pallor
  • Headaches
  • Cold hands and feet
  • Brittle nails or hair loss
  • Difficulty concentrating or brain fog
  • Restless legs
  • Reduced exercise tolerance

Notably, iron deficiency can cause meaningful symptoms even before the condition progresses to full anemia. Patients with low iron stores frequently report fatigue, cognitive difficulties, and reduced stamina, and research suggests that correcting iron deficiency may support improvements in these areas even when hemoglobin levels remain within reference ranges.⁴

Why Consider IV Iron Therapy with Venofer?

Oral iron is not ideal for every patient. First, there can be serious gastrointestinal side effects from oral iron supplements, such as:

  • Nausea
  • Constipation
  • Stomach pain
  • Diarrhea

Iron absorption can be exacerbated by systems, creating a downward spiral. In patients with inflammatory bowel disease, celiac disease, or a history of bariatric surgery, these symptoms may be impaired enough that oral iron cannot adequately correct the deficiency, regardless of how much you take. In patients with active blood loss or severe anemia, oral iron may simply work too slowly.Venofer IV addresses these limitations by delivering iron directly into circulation, bypassing the gastrointestinal tract entirely. Studies have shown that intravenous iron sucrose can rapidly increase hemoglobin, ferritin, and transferrin saturation levels with a well-tolerated safety profile. In many of them, a large percentage of adults with iron deficiency anemia who could not tolerate or did not improve with oral iron responded to intravenous iron sucrose therapy with meaningful improvements in hemoglobin.⁵ For patients who have struggled with oral supplementation, this can translate to a significant shift in how quickly they feel better.

Why Choose LCOA

Longevity Centers Of America

What Sets Longevity Centers of America Apart?

  • Personalized protocols tailored to your unique health goals
  • Physician-led team with advanced training in functional and longevity medicine
  • In-depth testing and root-cause diagnostics
  • Concierge-level care and long-term support
  • Proven therapies backed by science
  • A calm, comfortable, and discreet environment

What Our Venofer IV Approach Includes

At The Longevity Centers, every Venofer IV protocol is built around the individual patient’s needs, medical history, and laboratory findings. When you come in to meet with our clinical team, you can expect the following steps:

  • A comprehensive evaluation of iron status, including serum ferritin, transferrin saturation, and complete blood count
  • Investigation of the underlying cause of iron deficiency, whether nutritional, inflammatory, gastrointestinal, or related to blood loss
  • Personalized dosing and therapy schedule based on clinical guidelines and the severity of iron depletion
  • Administration of Venofer IV by qualified clinical staff in a supervised setting with appropriate monitoring
  • Follow-up laboratory testing to help confirm that iron stores have been replenished and to monitor ongoing status

The goal is not simply to deliver an Venofer infusion but to help address iron deficiency in an intentional, root-cause-focused way that also considers why the deficiency developed in the first place.

Who Should Consider Venofer IV?

Venofer IV may be a valuable option for patients whose iron deficiency or iron deficiency anemia has not been adequately addressed through diet and oral supplementation alone. This approach may be particularly beneficial if you:

  • Have been diagnosed with iron deficiency or iron deficiency anemia and are not responding well to oral iron
  • Experience significant gastrointestinal side effects from oral iron supplements
  • Have a history of inflammatory bowel disease, celiac disease, gastric bypass, or other conditions that impair iron absorption
  • Have experienced substantial blood loss from heavy menstrual cycles, gastrointestinal bleeding, or surgery
  • Are managing chronic kidney disease and require iron replenishment
  • Have ongoing fatigue, exercise intolerance, or cognitive difficulties associated with low iron stores
  • Want a faster and more efficient way to restore iron status than oral supplementation alone

Frequently Asked Questions

What is Venofer IV used for?

Venofer (iron sucrose) is an FDA-approved intravenous iron therapy for the treatment of iron deficiency anemia in patients with chronic kidney disease. It is also widely used in clinical practice to support patients with iron deficiency related to gastrointestinal disorders, heavy menstrual bleeding, pregnancy, bariatric surgery, and intolerance to oral iron supplementation. Your clinician can help determine whether Venofer IV is appropriate for your individual situation.

How quickly does Venofer IV work?

Iron sucrose is rapidly taken up by the bone marrow for incorporation into new red blood cells, and many patients begin to see improvements in hemoglobin and ferritin within weeks of beginning therapy. The exact timeline depends on the severity of the deficiency, the underlying cause, and the dosing protocol selected by the clinician. Some patients report improvements in energy and related symptoms even before laboratory markers are fully restored.

How is Venofer IV administered?

A venofer infusion is administered as a slow intravenous injection by qualified clinical staff in a medically supervised setting. Each Venofer dose takes a relatively short period of time, and the total therapy course typically involves several sessions scheduled over a defined period. Patients are monitored during and after administration to help ensure a safe and comfortable experience.

Are there any side effects of Venofer IV?

As with any medical therapy, there is a slight risk of Venofer side effects. The most commonly reported include headache, dizziness, nausea, muscle cramps, and injection site reactions. Serious hypersensitivity reactions are rare but possible, which is why Venofer IV should only be administered in a setting with trained personnel and appropriate monitoring. Your clinician will review your medical history to determine whether this therapy is a suitable option for you.


References

  1. “Anaemia,” World Health Organization, February 2025, https://www.who.int/news-room/fact-sheets/detail/anaemia
  2. Michael Auerbach and Iain C. Macdougall, “Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency,” Advances in Therapy, April 2020, https://www.researchgate.net/publication/340671237_Iron_Sucrose_A_Wealth_of_Experience_in_Treating_Iron_Deficiency
  3. “Iron deficiency anemia,” Mayo Clinic, September 2025, https://www.mayoclinic.org/diseases-conditions/iron-deficiency-anemia/symptoms-causes/syc-20355034
  4. Esa T. Soppi, “Iron deficiency without anemia – a clinical challenge,” Clinical Case Reports, April 2018, https://pmc.ncbi.nlm.nih.gov/articles/PMC5986027/
  5. Rodolfo Delfini Cançado, Pedro Otavio Novis de Figueiredo, Maria Cristina Albe Olivato, et al., “Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia,” Brazilian Journal of Hematology and Hemotherapy, January 2011, https://pmc.ncbi.nlm.nih.gov/articles/PMC3459362/.